217 related articles for article (PubMed ID: 33785062)
1. Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series.
Zhang RS; Padegimas A; Murphy KM; Evans PT; Peters CJ; Domenico CM; Vidula MK; Mather PJ; Cevasco M; Cohen RB; Carver JR; O'Quinn RP
Cardiooncology; 2021 Mar; 7(1):13. PubMed ID: 33785062
[TBL] [Abstract][Full Text] [Related]
2. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.
Nakagomi Y; Tajiri K; Shimada S; Li S; Inoue K; Murakata Y; Murata M; Sakai S; Sato K; Ieda M
Front Pharmacol; 2022; 13():884776. PubMed ID: 35645839
[No Abstract] [Full Text] [Related]
4. Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Balaji A; Hsu M; Lin CT; Feliciano J; Marrone K; Brahmer JR; Forde PM; Hann C; Zheng L; Lee V; Illei PB; Danoff SK; Suresh K; Naidoo J
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414264
[TBL] [Abstract][Full Text] [Related]
5. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.
Matzen E; Bartels LE; Løgstrup B; Horskær S; Stilling C; Donskov F
Cardiooncology; 2021 Aug; 7(1):27. PubMed ID: 34365980
[TBL] [Abstract][Full Text] [Related]
7. Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment.
Wang C; Lin J; Wang Y; Hsi DH; Chen J; Liu T; Zhou Y; Ren Z; Zeng Z; Cheng L; Ge J
Front Pharmacol; 2021; 12():770631. PubMed ID: 34938185
[No Abstract] [Full Text] [Related]
8. A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil.
Jespersen MS; Fanø S; Stenør C; Møller AK
Eur Heart J Case Rep; 2021 Nov; 5(11):ytab342. PubMed ID: 34870082
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis.
Thakker RA; Lee MA; Albaeni A; Elbadawi A; Suthar KH; Perez C; Sonstein LK; Farr NM; Venkatesan R; Khalife W; Berbarie RF; Chatila KF
Cardiol Res; 2021 Oct; 12(5):270-278. PubMed ID: 34691324
[TBL] [Abstract][Full Text] [Related]
10. Smoldering myocarditis following immune checkpoint blockade.
Norwood TG; Westbrook BC; Johnson DB; Litovsky SH; Terry NL; McKee SB; Gertler AS; Moslehi JJ; Conry RM
J Immunother Cancer; 2017 Nov; 5(1):91. PubMed ID: 29157297
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors in steroid and anti-TNF-alpha refractory immune checkpoint inhibitor colitis.
Zhang E; Kiely C; Sandanayake N; Tattersall S
JGH Open; 2021 May; 5(5):558-562. PubMed ID: 34013054
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid-resistant immune-related adverse events: a systematic review.
Daetwyler E; Wallrabenstein T; König D; Cappelli LC; Naidoo J; Zippelius A; Läubli H
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38233099
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
[TBL] [Abstract][Full Text] [Related]
14. Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression.
Mohammad KO; Fanous H; Vakamudi S; Liu Y
Cardiooncology; 2023 Mar; 9(1):15. PubMed ID: 36941689
[TBL] [Abstract][Full Text] [Related]
15. Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.
Dolladille C; Ederhy S; Allouche S; Dupas Q; Gervais R; Madelaine J; Sassier M; Plane AF; Comoz F; Cohen AA; Thuny FR; Cautela J; Alexandre J
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31988143
[TBL] [Abstract][Full Text] [Related]
16. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.
Liu Q; Yu Y; Lin J; Wang Y; Ai L; Li Q; Wu W; Jin H; Li S; Liu M; Yu S; Liu T
Eur J Cancer; 2021 Nov; 157():10-20. PubMed ID: 34464781
[TBL] [Abstract][Full Text] [Related]
18. Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis.
Townsend MJ; Hodi FS; Grover S
ACG Case Rep J; 2023 Mar; 10(3):e01018. PubMed ID: 36998343
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
Palaskas NL; Segura A; Lelenwa L; Siddiqui BA; Subudhi SK; Lopez-Mattei J; Durand JB; Deswal A; Zhao B; Maximilian Buja L; Iliescu C
Eur J Heart Fail; 2021 Oct; 23(10):1725-1735. PubMed ID: 34114291
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction.
Andres MS; Ramalingam S; Rosen SD; Baksi J; Khattar R; Kirichenko Y; Young K; Yousaf N; Okines A; Huddart R; Harrington K; Furness AJS; Turajlic S; Pickering L; Popat S; Larkin J; Lyon AR
Cardiooncology; 2022 Nov; 8(1):21. PubMed ID: 36424659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]